CASTRATION-SENSITIVE PROSTATE CARCINOMA
Clinical trials for CASTRATION-SENSITIVE PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CASTRATION-SENSITIVE PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for CASTRATION-SENSITIVE PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail aims to knock out prostate cancer spread
Disease control OngoingThis phase 2 trial tests whether adding apalutamide, abiraterone, and prednisone after chemotherapy can better control metastatic prostate cancer that still responds to hormone therapy. Seven men with high-risk, untreated disease are receiving this combination. The main goal is t…
Matched conditions: CASTRATION-SENSITIVE PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Prostate cancer patients may get a break from hormone shots
Disease control OngoingThis study looks at whether men whose metastatic prostate cancer has responded very well to hormone therapy can safely pause treatment. About 79 men will stop their medications under doctor guidance to see if their testosterone levels recover and they remain cancer-free for at le…
Matched conditions: CASTRATION-SENSITIVE PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC